1 Forgotten Weed Stock Could Make a Mighty Comeback in 2020

Investors dumped the Canopy Growth stock in 2019 because of its very disappointing performance. New catalysts, however, should help the most popular cannabis producer to make a mighty rebound in 2020.

| More on:
New year 2020 celebration. Gold foil balloons

Image source: Getty Images

The marijuana boom was supposed to happen last year. Many were expecting Canopy Growth (TSX:WEED)(NYSE:CGC) to lead the advance. All eyes, including that of Constellation Brands, were on its founder and erstwhile CEO Bruce Linton.

The American alcoholic beverage giant has a $4 billion investment, or 38% stake in the world’s largest publicly traded cannabis company by market value. With mounting losses after the Q2 2019, the Constellation Brands-controlled board has had enough of Linton’s free-spending ways.

Falling out

The board of directors felt a leadership change was in order, and Linton had to go. In spite of his termination in early July 2019, Linton bought WEED shares, saying the change signals the right time to buy.

From $53.52 on July 3, 2019, the price fell by nearly 65% to $18.78 in mid-November. The value of the entire cannabis industry also collapsed.

Canopy Growth was without a permanent CEO throughout the period. Also, it was dealing with supply issues and was having problems selling cannabis products abroad. More seriously, the company was losing money at a rapid pace.

Right man for the job

The good news came on December 9, 2019. As soon as the company announced the hiring of a new CEO, the stock rose to $28.17. Constellation chose a senior executive to take over the helm. It now appears that Canopy Growth is taking the right track in 2020.

Constellations Brand’s CFO David Klein is the chosen one. He’s leaving his post to take the helm at Canopy Growth effective January 14, 2020. Based on the company’s press release, Klein is the right man for the job.

He brings extensive experience from the consumer-packaged-goods (CPG) and the beverage alcohol industry. He has experienced too operating in highly regulated markets in Canada, Europe, Mexico, and the U.S.

With Klein’s strong financial orientation, expect Canopy Growth to depart from Linton’s boldness and do more belt-tightening. Some analysts, however, are uneasy about the appointment. Klein is facing an acid test given that he has zero experience in the cannabis arena.

Right product mix

A significant catalyst for Canopy Growth to stage a major comeback in 2020 is the improving demand trends in the domestic market. Canada’s Cannabis 2.0 is a potential $2.7 billion industry. Consumers can choose from a variety of product mixes in the legal channel, including the popular edibles.

Expect more retail stores to open too. Canopy Growth is opening ten of its Tokyo Smoke dispensaries in the province of Ontario to widen its retail footprint. Another segment in the derivatives where the company would focus on and lead is cannabis-infused beverages.

Right timing

Canopy Growth is hoping the U.S. federal legalization of cannabis would happen this year. The launching of Fire & Free, a line of hemp-derived CBD products, is part of its pre-legalization expansion. If both components in the U.S. progress well, Canopy Growth’s sales should rise significantly.

Right direction

While Canopy Growth is one of the stocks to watch in 2020, don’t expect instant financial miracles. The catalysts for growth are present, beginning with a new man at the helm. Product margins should improve as cash burn declines. You can decide to buy the stock once the red flags go down.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

2 Cannabis Stocks I’d Buy Over Canopy Growth

Here's why these two cannabis stocks are better long-term investments compared to Canopy Growth stock in 2023.

Read more »

edit Jars of marijuana
Cannabis Stocks

A Dividend Giant I’d Buy Over Canopy Growth Stock

Forget investing in a fundamentally weak stock such as Canopy Growth and buy shares of this cannabis REIT instead.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Corp: The Bottom Isn’t In

Canopy Growth Corp (TSX:WEED) is hitting new lows. Unfortunately, the bottom probably isn't in.

Read more »

edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Is Canopy Growth Stock a Buy in September?

Canopy Growth stock (TSX:WEED) has seen some major movement recently, with good news from the US boosting it further.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Will Canopy Growth Stock Continue to Surge in September 2023?

Canopy Growth stock has surged over 70% in the past week. Is WEED stock a good buy right now?

Read more »

A cannabis plant grows.
Cannabis Stocks

Is Canopy Growth Stock Worth a Buy in September?

Here's the bull and bear case behind whether Canopy Growth (TSX:WEED) stock is worth a speculative buy in September or…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Why Cannabis Stocks Are Flying Higher Again Today

Here’s why cannabis stocks, including TLRY, CRON, and ACB, are skyrocketing this week.

Read more »

A cannabis plant grows.
Cannabis Stocks

If You’d Invested $10,000 in Canopy Growth Stock When Cannabis Became Legal, Here’s What You’d Be Left with Today

A large investment in Canopy Growth Corp. (TSX:WEED) when cannabis was legalized may have seemed like a good idea at…

Read more »